PATENT CLAIM ANALYSIS

Application Number: 16345279
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["530", "387900"]

Abstract:
The invention relates to anti-Tau nanobodies.

Claim (Index 5):
The nanobody as claimed in  claim 1 , said nanobody comprising:\n a) the amino acid sequences (i) GRTFSSDT (SEQ ID No. 3) as CDR1, (ii) ISPSGGVT (SEQ ID No. 4) as CDR2 and (iii) NRDPKYGNTRY (SEQ ID No. 5) as CDR3; or b) the amino acid sequences (i) GRTFSRYA (SEQ ID No. 6) as CDR1, (ii) ISRSGGST (SEQ ID No. 7) as CDR2 and (iii) TARRRISGTPQWHY (SEQ ID No. 8) as CDR3; or a functionally conservative variant of the nanobody defined in a) or b) comprising a conservative substitution of one or two amino acids in, respectively, one, two or three of the sequences SEQ ID No. 3, SEQ ID No. 4 and SEQ ID No. 5, or SEQ ID No. 6, SEQ ID No. 7 and SEQ ID No. 8.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 100.0
- Lexical Diversity: 1.0
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14154954', '14705615', '15337964', '14348918', '15045804']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.667734153434953
- 35 USC 102 Novelty (BERT): 0.5149270876671299
- Combined Prediction Score: 0.6524534468581707
- Mean Citation Score: 260.888852
- Max Citation Score: 266.6617
- Similarity Product: 149.93593381639127

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test